altair_8k-083107.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
____________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (date of earliest event reported):
August 29, 2007
Altair
Nanotechnologies Inc.
(Exact
Name of Registrant as Specified in its Charter)
Canada
|
|
1-12497
|
|
33-1084375
|
(State
or other jurisdiction of
|
|
(Commission
|
|
(IRS
Employer
|
incorporation
or organization)
|
|
File
Number)
|
|
Identification
No.)
|
|
204
Edison Way
|
|
|
|
|
Reno,
NV
|
|
89502
|
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
|
Registrant's
Telephone Number, Including Area Code:
(775)
856-2500
N/A
(Former
name, former address, and formal fiscal year, if changed since last
report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
[
]
Written communications pursuant to Rule 425 under the Securities Act
(17
CFR
230.425)
[
]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR
240.14a-12)
[
]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[
]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c)
Item
5.02
|
Departure
of Directors or Certain Officers; Election of Directors; Appointment
of
Certain Officers; Compensatory Arrangements of Certain
Officers.
|
On
August
29, 2007, management of Altair Nanotechnologies Inc. (the “Company”) received a
copy of a letter from Christopher Jones, a director of the Company, announcing
his resignation from the Board of Directors of the Company effective September
30, 2007. Mr. Jones’ employer, Behr Process, Corp., is a competitor
of SherwinWilliams, an increasingly significant business parter of the Company,
and Mr. Jones determined that it would be in his best interest and that of
the
Company for him to resign before any conflicts arose. Management has
appreciated the contributions of Mr. Jones to the Company and wishes him
success
in the future.
The
Company has not identified a replacement for Mr. Jones but expects to appoint
a
successor as soon after September 30, 2007 as an appropriate successor has
been
identified.
SIGNATURES
Pursuant
to the requirements of the
Securities Exchange of 1934, the registrant has duly caused this report to
be
signed on its behalf by the undersigned hereunto duly
authorized.
Altair
Nanotechnologies Inc.
Dated: August
31,
2007
By:
/s/
Edward Dickinson
Edward
Dickinson, Chief Financial Officer
3